INSL3 and cryptorchidism: With the aim of evaluating the pituitary–testicular axis in patients with cryptorchidism, serum levels of another Sertoli cell marker—inhibin B—and of Leydig cell markers—testosterone and INSL3—have also been assessed in different studies.